Clinical Trials Browser

Phase 3 × OTHER × polatuzumab vedotin × Clear all

NCT04833114 2025-09-30

Pola-R-ICE

Phase 3 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT06522555 2024-08-05

The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma

Phase 3 Recruiting

Lymphoma, Large B-Cell, Diffuse